HIV prevention randomized clinical trials: quantitative and analytical insights on the failure to measure efficacy  by Cuadros, D. et al.
l of In
s
o
a
m
p
t
r
t
t
d
r
r
s
t
t
h
h
T
F
S
D
T
R
C
t
a
A
1
(
2
3
4
v
r
4
6
3
s
a
c
F
2
t
o
l
a
c
o
o
3
1
(
3
615th ICID Abstracts / International Journa
pective of the sexual-risk distribution. This pattern is suggestive
f a modulated threshold effect. We found that this effect reﬂects
modulated form of the R0=1 sustainability threshold. The vast
ajority of HIV transmissions were found occurring from infected
ersons in the higher risk groups, though lower risk groups con-
ributed as much as one-third of HIV acquisitions. The incidence
ate was found to follow a power law and to be a direct measure of
he level of risk.
Conclusion:Our study indicates distinctive patterns for the dis-
ribution of HIV infection in human populations. HIV transmission
ynamics is dominated by the behavior of individuals in the higher
isk groups above an HIV sustainability threshold, while the lower
isk groups are still at risk as the receptive ends of HIV transmis-
ion chains. The presence of mixing in the population merely acts
o modulate this threshold by allowing some HIV prevalence in
he lower risk groups and a smooth transition of prevalence to the
igher risk groups.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.737
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Background: Nigeria contributes 15-30% of global gap on Pre-
ention of Mother-to-Child Transmission (PMTCT). In pregnancy,
isk of Human immunodeﬁciency virus (HIV) transmission is 30%-
5%, reducible to <2% with PMTCT services. Oyo’s population of
,392,365 (women of childbearing ages-22%) and HIV prevalence
.0% in 2010, created a high need for PMTCT. We conducted this
tudy in October 2011 to determine PMTCT service coverage and
cceptance amongst pregnant women (PW) attending ante-natal
are (ANC) with a view to making recommendations.
Methods: We used retrospective cohort study design as Health
acilities (HF) health records review from January-December
010.We desk reviewed all HF in the state for those offering PMTCT
odetermine coverage/acceptability/ownership.Weextracteddata
n ANC attendance, HIV screening, antiretroviral (ARV) prophy-
axis, positive (+) PW’s delivery for PW aged 15-49 years who
ttended ANC for the period. We conducted analyses for frequen-
ies/proportions using MS Excel.
Results: Of 1,169 HFs, 10 (0.9%) located in 8/33 LGA (24%)
ffered PMTCT. 5/10 (50%) were private-owned. 90,982 (28.5%)
f 319,618 annual PW in state had at least one ANC visit.
6,804/90,982 (40.5%) seen/had access to PMTCT service in the
0 HF, representing 36,804/319,618 (11.5%) of all PW. 36,740
99.8%) of these accepted HIV screening. Among those screened
6,634 (99.7%) received result, 615 (1.7%) were reactive, all
15 accepted infant feeding/family-planning counseling. 523(85%)fectious Diseases 16S (2012) e158–e316 e181
HIV+PW were placed on ARV prophylaxis, 317 babies born to
HIV+PW.
Conclusion: PMTCT coverage and ANC attendance in Oyo State
were poor. Most PW couldn’t access PMTCT, creating HIV risk for
unborn child. Its acceptance was high in HF offering it. Recom-
mendations and advocacy were made. PMTCT scale-up plans are
being developed to achieve universal access and zero transmission
in pregnancy.
http://dx.doi.org/10.1016/j.ijid.2012.05.738
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Background: During the nearly 30 years of research on HIV,
more than 40 randomized controlled trials (RCT) have been
designed to measure the efﬁcacy of interventions on HIV incidence
ranging from HIV vaccines to behavioral interventions. Despite the
solid foundation on observational epidemiological evidence, nearly
90% of the RCTs failed to measure a statistically signiﬁcant efﬁ-
cacy against HIV incidence. The reasons behind the failure of most
RCTs to measure efﬁcacy continue to be poorly understood. In this
study, we implemented in silico simulations of an RCT to explore
the drivers of the failures of a landmarkHIV clinical trial tomeasure
a statistically signiﬁcant efﬁcacy.
Methods: We simulated the Partners in Prevention HSV/HIV
transmission study designed to test the efﬁcacy of herpes simplex
virus type 2 (HSV-2) suppressive therapy by acyclovir in reduc-
ing HIV transmission. We also simulated different variations of
this trial, and the Rakai male circumcision trial. We developed
individual-based Monte-Carlo models parameterized by the data
of these RCTs and simulated the RCTs 1000 times. To measure the
efﬁcacy of the intervention, we conducted a log-rank survival anal-
ysis for each RCT realization and estimated the statistical power as
the fraction of realizations that rejected the null hypothesis.
Results: Our analyses indicated that the Partners in Prevention
RCT had only 14% likelihood to observe a statistically signiﬁcant
efﬁcacy for the intervention. In contrast, a different and more
potent regimen forHSV-2 suppression had 87% chance of observing
a statistically signiﬁcant efﬁcacy. For the Rakai male circumcision
trial simulation, 94% of the RCT realizations showed statistically
signiﬁcant efﬁcacy for the intervention.
Conclusion: Our results suggest that the outcome of the Part-
ners inPrevention trial couldhavebeenanticipated, at least to some
extent. The simulations indicate that several unexpected odds have
colluded to undermine the statistical power of the study, and there-
fore it would be premature to discredit the concept of acyclovir
therapy for HIV prevention based on the outcome of the Partners
in Prevention trial. Our study highlights how in silico simulations
of RCTs can provide powerful tools to enhance the success of any
HIV intervention RCT.
http://dx.doi.org/10.1016/j.ijid.2012.05.739
